Get all your news in one place.

100's of premium titles.
One app.

Get all your news in one place.

100's of premium titles. One news app.

The Latest Breaking News from Eli Lilly and Company

3 Rising Pharma Stocks to Consider Buying Now

The pharmaceutical sector is transforming due to the swift uptake of digital solutions and worldwide spending growth. Hence, fundamentally strong pharma stocks Supernus Pharmaceuticals (SUPN), Astellas Pharma (ALPMY), and Eli Lilly (LLY) might be solid buys now. Read more….

StockNews.com

Career advice from the CFOs of Dell, Eli Lilly, and Marriott—3 women who have each spent 20-plus years climbing the ladder at one company

As the CFO role continues to evolve, the leaders also explained the integral part of being an effective finance chief.

Fortune

Eli Lilly’s CFO explains why the company’s newest weight-loss drug Zepbound will cost 20% less than the current options

Zepbound is expected to be available in the U.S. by the end of the year.

Fortune

From analysis to the latest developments in health,
read the most diverse news in one place.

Eli Lilly & Co. (LLY) Earnings Forecast

Drugmaker Eli Lilly and Company (LLY) is scheduled to release its third-quarter results soon. While its revenue is expected to rise sharply over the prior-year quarter, its earnings are expected to decline. So, how should investors position themselves before the results are out? Read on to learn more….

StockNews.com

Prescribe to Profits With These 3 Pharma Stocks

The pharma industry looks well-positioned for solid growth in the long term amid the rising incidence of chronic illnesses and technological advancements. So, quality pharma stocks, Eli Lilly and Company (LLY), Merck & Co. (MRK), and Teva Pharmaceutical (TEVA) could be profitable investments. Read on.

StockNews.com

3 Pharma Stocks Smart Money Is Following in September

With the rising prevalence of chronic diseases, the demand for pharmaceutical products is anticipated to rise. Therefore, investors could consider buying three fundamentally robust pharma stocks, Eli Lilly and Company (LLY), Zoetis (ZTS), and Taro Pharmaceutical Industries (TARO), which are gaining traction among institutional investors this month. Learn more….

StockNews.com

Top 3 Pharma Stocks You Can’t Miss out On

The ever-transforming pharmaceuticals sector is ready to seize the opportunity to address the growing demand for healthcare across the globe. Therefore, adding these three quality pharma stocks, Johnson & Johnson (JNJ), Eli Lilly and Company (LLY), and Dr. Reddy's Laboratories (RDY), to your portfolio could prove to be beneficial. Read…

StockNews.com

Read news from The Economist, FT, and more,
with one subscription

Should Investors Start Watching Eli Lilly & Co. (LLY) This Week?

Despite macroeconomic headwinds dampening the growth of various industries, Eli Lilly and Company (LLY) has remained resilient and is ramping up investments in medical research. So, will it be a good watchlist addition this week? Keep reading.

StockNews.com

New drug found to slow Alzheimer’s hailed as turning point

Donanemab has been found to slow down the disease in a clinical trial.

The Independent UK

Alzheimer’s: ‘Turning point’ in fight against disease as drug found to slow decline by up to 35%

Experts say ‘we’re entering a new era where Alzheimer’s disease could become treatable’

Evening Standard

3 Safe Stocks to Buy Hand Over Fist Right Now

The recent financial system failures and macroeconomic headwinds have weighed heavily on investors’ sentiments. Amid rekindled recessionary fears, quality stocks Eli Lilly (LLY), McDonald's Corp. (MCD), and Cigna Corp. (CI) might be safe portfolio additions now. Read on….

StockNews.com

5 Best Pharma Stocks to Buy Right Now

The pharma industry has experienced tremendous growth in recent years and should continue to grow amid the integration of advanced technologies. Hence, pharma stocks Eli Lilly (LLY), Takeda Pharmaceutical (TAK), Catalyst Pharmaceuticals (CPRX), Poseida Therapeutics (PSTX), and Voyager Therapeutics (VYGR) might be worth buying right now. Read on.

StockNews.com

The 5 Safest Stocks You Can Buy in 2023

The stock market might remain volatile in the near term amid the still-alarmingly high inflation and the anticipated continuation of rate hikes. Therefore, fundamentally strong Eli Lilly (LLY), Novartis (NVS), Comcast (CMCSA), HCA Healthcare (HCA), and Myers Industries (MYE), which pay steady dividends, might be safe buys now. Read more.

StockNews.com

3 Large-Cap Stocks to Buy for the Perfect Portfolio in 2023

While the easing inflation and strong labor market have been boosting consumer confidence, uncertainties remain. Moreover, the Fed’s interest rate hikes might continue longer than many think. Therefore, fundamentally sound large-cap stocks, Visa (V), Eli Lilly (LLY), and Merck & Co (MRK), could be ideal buys to navigate the economic…

StockNews.com

Get all your
news in one place.

100's of premium titles.
One news app.

StockNews.com

3 Large-Cap Stocks Worth Buying in 2023

With the Fed signaling to continue raising interest rates throughout this year, the probability of the economy tipping into a recession is increasing. Amid the macroeconomic unrest, fundamentally sound large-cap stocks UnitedHealth Group (UNH), Walmart (WMT), and Eli Lilly (LLY) might be safe investments this year. Read on….

Benzinga

Block, Eli Lilly And 2 Other Stocks Insiders Are Selling

The US economy added 261,000 jobs in October, while the unemployment rate increased to 3.7% during the month. Investors, meanwhile, focused on some notable insider trades.

StockNews.com

2 Pharma Stocks You'll Want to Pay Attention to This Fall

Although the stock market has been under pressure this year due to macroeconomic headwinds, the pharmaceutical industry continues to garner investor attention as it enjoys inelastic demand for its products regardless of economic conditions. Thus, fundamentally-sound pharma stocks Eli Lilly (LLY) and Bristol-Myers Squibb (BMY) could be worth your attention…

StockNews.com

3 Names It Wouldn’t Hurt to Stock up On

Despite the Fed’s continued hawkish stance, the September inflation report came in hotter than expected, raising the possibility of another aggressive interest rate hike in November. However, it could be smart to keep investing in quality stocks to benefit from their rebound. We think Microsoft (MSFT), Eli Lilly (LLY), and…

Get all your
news in one place.

100's of premium titles.
One news app.

StockNews.com

2 Stocks That Could Be Long-Term Winners for Investors

With the economy reporting two consecutive quarters of GDP decline, many analysts believe that the economy has already entered a recession. During periods of market uncertainty, investors should look for stocks that could win in the long run based on their strong fundamentals and solid growth prospects. We think Pfizer…

StockNews.com

3 Dividend-Paying Stocks to Consider During a Recession

Rising inflation, the Fed’s hawkish stance to tame it, and an economic contraction for two consecutive quarters have stoked fears of a recession in the U.S. economy. Amid the likely economic downturn, investors could consider investing in stocks that provide a steady income in the form of dividends. Therefore, we…

StockNews.com

Is Biotech Ready for Another Bull Run? 3 Stocks to Get in Ahead of the Crowd

The biotech industry flourished during the height of the COVID-19 pandemic and reported record revenues and earnings last year. Despite the market slowdown, the sector is poised for another bull run, given the continued global fight against COVID-19 and the increasing demand with an aging population. Popular biotech stocks Pfizer…

Benzinga

Executives Sell More Than $67M Of 5 Stocks: NetApp, Eli Lilly And More

US gold futures traded lower on Friday. Investors, meanwhile, focused on some notable insider trades.

StockNews.com

LLY's New Drug Lineup Looks Promising For Investors

Eli Lilly and Company’s (LLY) new drug line-up is expected to generate higher revenues and earnings. Also, LLY’s robust earnings, favorable analyst estimates, and higher-than-industry profitability make it a promising investment option. Read on….

StockNews.com

5 Stocks Upgraded To "Strong Buy" Last Week

Investors’ concerns over the impending interest rate hikes are expected to keep the markets highly volatile in the near term. Therefore, it could be wise to invest in fundamentally-sound stocks Group 1 Automotive (GPI), Eli Lilly and Company (LLY), nVent Electric (NVT), Primo Water (PRMW), and Sanmina (SANM) that are…

StockNews.com

3 Growth Stocks to Buy if You Think Inflation Has Peaked

A slightly lower consumer price index in April and expectations of a flat or lower CPI in May indicate inflation may have peaked. Yesterday, the major U.S. stock indices increased slightly as leading growth stocks rallied. Given this backdrop, we think it could be wise to invest in the shares…

1 2 3

People

Kritika SarmahHer

727 stories

Dipanjan BanchurSince

From analysis to the latest developments in health,
read the most diverse news in one place.

Organisations

Read news from The Economist, FT, and more,
with one subscription

Topics

Places

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.